ES2091161A1 - Process for the production of intramuscular gamma globulin inactivated by pasteurization - Google Patents
Process for the production of intramuscular gamma globulin inactivated by pasteurizationInfo
- Publication number
- ES2091161A1 ES2091161A1 ES09500730A ES9500730A ES2091161A1 ES 2091161 A1 ES2091161 A1 ES 2091161A1 ES 09500730 A ES09500730 A ES 09500730A ES 9500730 A ES9500730 A ES 9500730A ES 2091161 A1 ES2091161 A1 ES 2091161A1
- Authority
- ES
- Spain
- Prior art keywords
- pasteurization
- intramuscular
- inactivated
- production
- gamma globulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Process for the production of intramuscular gamma globulin inactivated by pasteurization. Process for the preparation of multipurpose or specific intramuscular gamma globulins which includes a stage of specific viral inactivation by pasteurization in solution. Under the conditions of the process according to this invention no significant change in the Ig molecules or their biological antibody activities, or the presence of aggregate or denatured molecular forms, is detected. It has antitetanus, antihepatitis and anti-D (Rh) applications.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9500730A ES2091161B1 (en) | 1995-04-12 | 1995-04-12 | PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9500730A ES2091161B1 (en) | 1995-04-12 | 1995-04-12 | PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2091161A1 true ES2091161A1 (en) | 1996-10-16 |
ES2091161B1 ES2091161B1 (en) | 1997-05-16 |
Family
ID=8290085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9500730A Expired - Fee Related ES2091161B1 (en) | 1995-04-12 | 1995-04-12 | PROCEDURE FOR THE PRODUCTION OF INTRAMUSCULAR GAMMAGLOBULIN INACTIVATED BY PASTEURIZATION. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2091161B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2381828A1 (en) * | 2012-03-20 | 2012-06-01 | Grifols, S.A. | Process for obtaining an IgG composition through heat treatment |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
EP0196761A2 (en) * | 1985-02-21 | 1986-10-08 | Green Cross Corporation | Method of virus-inactivating heat treatment of gamma-globulin |
EP0278422A2 (en) * | 1987-02-06 | 1988-08-17 | Green Cross Corporation | y-Globulin injectable solutions |
ES2034999T3 (en) * | 1986-07-09 | 1993-04-16 | Green Cross Corporation | PROCEDURE FOR THERMAL TREATMENT OF GAMMA-GLOBULIN CHEMICALLY NOT MODIFIED. |
-
1995
- 1995-04-12 ES ES9500730A patent/ES2091161B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
EP0196761A2 (en) * | 1985-02-21 | 1986-10-08 | Green Cross Corporation | Method of virus-inactivating heat treatment of gamma-globulin |
ES2034999T3 (en) * | 1986-07-09 | 1993-04-16 | Green Cross Corporation | PROCEDURE FOR THERMAL TREATMENT OF GAMMA-GLOBULIN CHEMICALLY NOT MODIFIED. |
EP0278422A2 (en) * | 1987-02-06 | 1988-08-17 | Green Cross Corporation | y-Globulin injectable solutions |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2381828A1 (en) * | 2012-03-20 | 2012-06-01 | Grifols, S.A. | Process for obtaining an IgG composition through heat treatment |
EP2641912A1 (en) | 2012-03-20 | 2013-09-25 | Grifols, S.A. | Process for obtaining an IgG composition through heat treatment |
CN103319592A (en) * | 2012-03-20 | 2013-09-25 | 基立福有限公司 | Process for obtaining an IgG composition through heat treatment |
AU2013201853B2 (en) * | 2012-03-20 | 2014-07-03 | Grifols, S.A. | Process for obtaining an lgG composition through heat treatment |
US9200032B2 (en) | 2012-03-20 | 2015-12-01 | Grifols, S.A. | Process for obtaining an IgG composition through heat treatment |
CN103319592B (en) * | 2012-03-20 | 2020-03-03 | 基立福有限公司 | Method for obtaining an IgG composition by heat treatment |
Also Published As
Publication number | Publication date |
---|---|
ES2091161B1 (en) | 1997-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT994903E (en) | METHODS AND COMPOSITIONS FOR GALACTOSILED GLICOPROTEINS | |
ATE425989T1 (en) | PROTEIN PURIFICATION PROCESS | |
EP1801591A3 (en) | Methods for detection or measurement of viruses | |
DE60207848D1 (en) | METHOD FOR THE PRODUCTION OF CONCENTRATED HUMAN IMMUNOGLOBULINS FOR THERAPEUTIC USE | |
DE69424545D1 (en) | METHOD FOR PRODUCING IMMUNOGLOBULIN G CONCENTRATE | |
AR248044A1 (en) | Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5. | |
ATE367830T1 (en) | DEVICE FOR INACTIVATION OF VIRAL CONTAMINATIONS IN BLOOD PRODUCTS | |
NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
DE69839218D1 (en) | METHOD FOR REMOVING VIRUSES | |
PL340449A1 (en) | Highly efficient method of functionally classifying proteins identified by gnomic techniques | |
ATE278785T1 (en) | NEW METHOD FOR OBTAINING AND PURIFYING FUSION PROTEINS | |
DE69626683D1 (en) | METHOD FOR DETECTING ANTIPOLYMER ANTIBODIES AND DIAGNOSTIC TEST SET FOR DETECTING SILICONE-DEPENDENT DISEASES | |
ATE212065T1 (en) | NUCLEIC ACID MOLECULES WITH THE CAPABILITY OF DISTINCTING PRPC AND PRPSC PRION PROTEIN ISOFORMS AND METHODS FOR THE PRODUCTION THEREOF | |
ES2148577T3 (en) | ELIMINATION OF INTERFERENCES CAUSED BY RHEUMATOID FACTORS THROUGH ANTI-FD ANTIBODIES. | |
ATE206621T1 (en) | IL-8 ANTAGONISTS FOR THE TREATMENT OF ASTHMA | |
ES2091161A1 (en) | Process for the production of intramuscular gamma globulin inactivated by pasteurization | |
ES2100340T3 (en) | SYNTHETIC CDW52 PEPTIDIC ANTIGEN (CAMPATH-1). | |
ATE461935T1 (en) | METHOD FOR PURIFYING STRONGLY ANIONIC PROTEINS | |
ATE227307T1 (en) | METHOD FOR PRODUCING MODIFIED PROTEINS | |
ATE214430T1 (en) | METHOD FOR DETECTING LIVE MICROBIOLOGICAL CONTAMINANTS IN A FOOD SAMPLE | |
EP1104310A4 (en) | Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response | |
MX9605278A (en) | Process for virus inactivation in proteins. | |
ATE229339T1 (en) | INHIBITOR OF IMMUNOGLOBULIN E ANTIBODIES GENERATION FOR THE TREATMENT OF TYPE I ALLERGY-RELATED DISEASES | |
ATE309371T1 (en) | PROTEIN WITH DNASE ACTIVITY | |
DK0774119T3 (en) | Oligomeric carrier molecules having defined groups and haptenes incorporated in a defined manner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19961016 Kind code of ref document: A1 Effective date: 19961016 |
|
EC2A | Search report published |
Date of ref document: 19961016 Kind code of ref document: A1 Effective date: 19961016 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20150826 |